Business Description
TMC Life Sciences Bhd
ISIN : MYQ0101OO004
Compare
Compare
Traded in other countries / regions
0101.Malaysia IPO Date
2005-10-06Description
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.86 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.23 | |||||
| Debt-to-EBITDA | 2.68 | |||||
| Interest Coverage | 3.7 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.73 | |||||
| Beneish M-Score | -2.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 20.1 | |||||
| 3-Year EBITDA Growth Rate | 29.4 | |||||
| 3-Year EPS without NRI Growth Rate | 24.2 | |||||
| 3-Year Book Growth Rate | 4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.85 | |||||
| 9-Day RSI | 28.31 | |||||
| 14-Day RSI | 29.75 | |||||
| 6-1 Month Momentum % | -19.85 | |||||
| 12-1 Month Momentum % | -20.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.77 | |||||
| Quick Ratio | 2.64 | |||||
| Cash Ratio | 1.91 | |||||
| Days Inventory | 44.51 | |||||
| Days Sales Outstanding | 57.68 | |||||
| Days Payable | 223.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.83 | |||||
| Dividend Payout Ratio | 0.24 | |||||
| 3-Year Dividend Growth Rate | 26 | |||||
| Forward Dividend Yield % | 0.97 | |||||
| 5-Year Yield-on-Cost % | 1.6 | |||||
| Shareholder Yield % | 2.15 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 69.92 | |||||
| Operating Margin % | 11.11 | |||||
| Net Margin % | 8.47 | |||||
| FCF Margin % | 4.58 | |||||
| ROE % | 3.22 | |||||
| ROA % | 2.39 | |||||
| ROIC % | 3.03 | |||||
| ROC (Joel Greenblatt) % | 6.51 | |||||
| ROCE % | 4.3 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 29.71 | |||||
| PE Ratio without NRI | 29.71 | |||||
| Shiller PE Ratio | 8.35 | |||||
| PEG Ratio | 1.93 | |||||
| PS Ratio | 2.62 | |||||
| PB Ratio | 0.99 | |||||
| Price-to-Tangible-Book | 1.29 | |||||
| Price-to-Free-Cash-Flow | 50.5 | |||||
| Price-to-Operating-Cash-Flow | 16.83 | |||||
| EV-to-EBIT | 19.33 | |||||
| EV-to-EBITDA | 12.06 | |||||
| EV-to-Revenue | 2.71 | |||||
| EV-to-FCF | 59.05 | |||||
| Price-to-Projected-FCF | 2.4 | |||||
| Price-to-DCF (Earnings Based) | 0.95 | |||||
| Price-to-DCF (FCF Based) | 4.21 | |||||
| Price-to-Median-PS-Value | 0.49 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.53 | |||||
| Price-to-Graham-Number | 1.29 | |||||
| Earnings Yield (Greenblatt) % | 5.17 | |||||
| FCF Yield % | 1.75 | |||||
| Forward Rate of Return (Yacktman) % | 16.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TMC Life Sciences Bhd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil RM) | 335.947 | ||
| EPS (TTM) (RM) | 0.017 | ||
| Beta | 0.28 | ||
| Volatility % | 23.82 | ||
| 14-Day RSI | 29.75 | ||
| 14-Day ATR (RM) | 0.007433 | ||
| 20-Day SMA (RM) | 0.52 | ||
| 12-1 Month Momentum % | -20.44 | ||
| 52-Week Range (RM) | 0.5 - 0.81 | ||
| Shares Outstanding (Mil) | 1,741.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TMC Life Sciences Bhd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TMC Life Sciences Bhd Stock Events
| Event | Date | Price(RM) | ||
|---|---|---|---|---|
| No Event Data | ||||
TMC Life Sciences Bhd Frequently Asked Questions
What is TMC Life Sciences Bhd(XKLS:0101)'s stock price today?
The current price of XKLS:0101 is RM0.51. The 52 week high of XKLS:0101 is RM0.81 and 52 week low is RM0.50.
When is next earnings date of TMC Life Sciences Bhd(XKLS:0101)?
The next earnings date of TMC Life Sciences Bhd(XKLS:0101) is .
Does TMC Life Sciences Bhd(XKLS:0101) pay dividends? If so, how much?
The Dividend Yield %  of TMC Life Sciences Bhd(XKLS:0101) is 0.83% (As of Today), Highest Dividend Payout Ratio of TMC Life Sciences Bhd(XKLS:0101) was 0.6. The lowest was 0.08. And the median was 0.17. The  Forward Dividend Yield % of TMC Life Sciences Bhd(XKLS:0101) is 0.97%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers